Diamyd Medical AB (publ) (DMYD-B) — Cash Flow Reinvestment Rate

Latest as of November 2021: 2978.57x

Diamyd Medical AB (publ) (DMYD-B) has a Cash Flow Reinvestment Rate of 2978.57x as of November 2021, reinvesting Skr62.55 Million (capex Skr42.55 Million plus investments Skr-20.00 Million) from operating cash flow of Skr21.00K. Explore how much does Diamyd Medical AB (publ) reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

2978.57x
(Capex + Investments) / Operating CF

Total Reinvested

Skr62.55 Million
Capex + Investments

Operating Cash Flow

Skr21.00K
SEK

Capital Expenditures

Skr42.55 Million
SEK

Diamyd Medical AB (publ) Cash Flow Reinvestment Rate (2010–2020)

Historical reinvestment intensity for Diamyd Medical AB (publ) across 2 annual periods. Also explore total assets of Diamyd Medical AB (publ) for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Diamyd Medical AB (publ) (2010–2020)

Year-by-year capital reinvestment analysis for Diamyd Medical AB (publ). For live market cap and broader valuation context, see how much is Diamyd Medical AB (publ) worth.

Year Reinvestment Rate Total Reinvested (SEK) Operating CF Capex YoY Change
2020 0.52x Skr8.78 Million Skr16.88 Million Skr1.98 Million ▲ +16674.5%
2010 0.00x Skr700.00K Skr225.77 Million Skr700.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow